Company: SGBAF
Filing Date: 2025-04-23
Form Type: DRS/A
Source: 0000950123-25-003652
Chunk: 508

Company: SES S.A.
Filing Date: 2025-04-23
Form: DRS/A
Chunk 508
---
.S. Department of Commerce’s Bureau of Industry and Security and the International Traffic in Arms Regulations (“”) administered by the U.S. Department of

A-14

Confidential Treatment Requested by SES

Pursuant to 17 C.F.R. Section 200.83

State’s Directorate of Defense Trade Controls (“”)), Regulation (EU) 2021/821 of the European Parliament and the Council of 20 May 2021 setting up a Union regime
for the control of exports, brokering, technical assistance, transit and transfer of dual-use items (recast), economic and financial sanctions (including economic and financial sanctions administered by the
U.S. Department of the Treasury’s Office of Foreign Assets Control, or by the relevant authorities in the European Union and its Member States, and the United Kingdom), and trade embargoes, boycotts and anti-boycotts, imports of goods and
payment of custom duties as applied by the relevant agencies in the various jurisdictions.

“”
means, collectively, (a) the Closing Cash Consideration, (b) the CVR Consideration, (c) the Liabilities Assumption and (d) the Applicable Spectrum Additional Consideration, if any.

“” means, as at any specified time, the aggregate amount of any and all (a) fees and expenses
(including any Liquidation Expenses incurred prior to the Closing) accrued or incurred prior to or at the Closing and paid or payable by Indiana or any of its Subsidiaries or any Person that Indiana pays or reimburses (including Indiana
Shareholders) or is otherwise legally obligated to pay or reimburse in connection with (i) the negotiation, preparation or execution of this Agreement or the Ancillary Agreements and/or the performance or consummation of the Transactions,
including all fees and expenses of counsel, advisors, consultants, investment bankers, accountants, auditors and any other experts, and all brokers’, finders’ or similar fees or (ii) any efforts to obtain any consent, decision,
declaration, approval, clearance, or waiver, or expiration or termination of a waiting period by or from, or to avoid or defend against any Action by any Governmental Authority in connection with any Antitrust Law, including any Regulatory
Litigation Expenses, and (b) Employee Transaction Payments; that Transaction Expenses shall not include (A) any such fees or expenses paid by Indiana or any of its Subsidiaries or any Person on or prior to January 29,
2024 in connection with